SOURCE: BioDrain Medical Inc.

BioDrain Medical Inc.

September 07, 2011 08:00 ET

BioDrain to Present at the Rodman & Renshaw Healthcare Conference in New York City on Monday, September 12

MINNEAPOLIS, MN--(Marketwire - Sep 7, 2011) - BioDrain Medical, Inc. (OTCBB: BIOR) (OTCQB: BIOR), producer of the FDA cleared Streamway® System for automated surgical fluid disposal, will present detailed information about the Company's expanding commercialization opportunities at the Rodman and Renshaw Annual Healthcare Conference, being held at the Waldorf Astoria Hotel in New York city from September 11-13, 2011. Kevin Davidson, Chief Executive Officer of BioDrain, will present the Company's latest developments on Monday, September 12, at 4:55 p.m.

"I am delighted our Company has been invited to present at Rodman and Renshaw's prestigious Healthcare Conference," declared Mr. Davidson. "We have made important business advances in recent months and we are eager to share this information with the wide range of investment companies that attend this conference. We believe investors will recognize that BioDrain is at a critical inflexion point, with a rapidly growing demand for demonstrations of our Streamway System from hospitals and surgical centers across the country. As these medical centers recognize the safety, low cost, improved environmental impact and efficiency of the Streamway System, we anticipate these demonstrations will lead to increased purchase orders. We look forward to discussing the investment potential of supporting our drive to meet the anticipated demand."

About BioDrain Medical, Inc.
BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid disposal system that virtually eliminates operating room workers' exposure to blood, irrigation fluid and other potentially infectious fluids found in the surgical environment. Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an antiquated approach to the handling of surgical fluid waste. BioDrain's Streamway System fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the operating room (and thereby making surgeries more profitable).

BioDrain's Streamway System is eco-friendly as it contributes to cleaning up the environment. Currently, approximately 50 million bloody, potentially disease infected canisters go to landfills annually in the United States. These tainted canisters can remain in landfills for years to come. With the installation of BioDrain's Streamway System, the number of canisters can be significantly reduced. BioDrain Medical, Inc. makes the operating room and our environment safer, cleaner, and better. BioDrain products are currently being represented by independent professional sales representatives that cater to the needs of hospitals and ambulatory surgical centers across the country. For additional information, please visit: www.biodrainmedical.com.

Forward-looking Statements:
Certain of the matters discussed in this announcement contain forward-looking statements that involve material risks to and uncertainties in the company's business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the company's ability to implement its long range business plan for various applications of its technology; the company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the company's reports filed with the Securities and Exchange Commission. This is not a solicitation to buy or sell securities and does not purport to be an analysis of the company's financial position. See the company's most recent Quarterly Report on Form 10-Q and related 8-K filings.

Contact Information

  • Investor Relations Contact:
    Stanley Wunderlich
    Consulting for Strategic Growth 1 Ltd.
    Tel: 800-625-2236 ext. 7770
    Email: Email Contact